PARIS - Novagali Pharma closed a third funding round in which it raised €26 million from its existing investors and two newcomers, bringing to €44 million (US$54.6 million) the total funding it has raised since it was founded in August 2000. (BioWorld International)
PARIS - Novagali Pharma closed a third funding round in which it raised €26 million from its existing investors and two newcomers, bringing to €44 million (US$54.6 million) the total funding it has raised since it was founded in August 2000. (BioWorld International)
PARIS - Innate Pharma SAS and the Danish pharmaceutical company Novo Nordisk A/S entered into a strategic partnership to develop new drugs targeting natural killer (NK) cells for the treatment of cancer, autoimmune disorders and infectious diseases. (BioWorld International)
PARIS - Innate Pharma SAS and the Danish pharmaceutical company Novo Nordisk A/S entered into a strategic partnership to develop new drugs targeting natural killer (NK) cells for the treatment of cancer, autoimmune disorders and infectious diseases. (BioWorld International)
